Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling
出版年份 2023 全文链接
标题
Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling
作者
关键词
-
出版物
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-31
DOI
10.1111/jcmm.18000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PPAR-γ Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1α/Δψm Pathways by Inhibiting Pyroptosis
- (2023) Zhencheng Feng et al. PPAR Research
- Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice
- (2023) Lei Wang et al. INFLAMMOPHARMACOLOGY
- Inflammasome activation and pyroptosis via a lipid-regulated SIRT1-p53-ASC axis in macrophages from male mice and humans
- (2022) Yimao Huang et al. ENDOCRINOLOGY
- Oridonin alleviates hyperbilirubinemia through activating LXRα-UGT1A1 axis
- (2022) Zhikun Zhan et al. PHARMACOLOGICAL RESEARCH
- Intestinal fatty acid binding protein: A rising therapeutic target in lipid metabolism
- (2022) Xi Huang et al. PROGRESS IN LIPID RESEARCH
- Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells
- (2021) Sabrina Robichaud et al. Autophagy
- Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
- (2021) Salim S. Virani et al. CIRCULATION
- Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 monoclonal antibodies
- (2021) Adel Hajj Ali et al. CURRENT MEDICINAL CHEMISTRY
- IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2021) Paul M Ridker et al. LANCET
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB
- (2021) Yu Zhu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE−/− mice atherosclerosis
- (2021) Lingbo Xu et al. LABORATORY INVESTIGATION
- Network pharmacology: curing causal mechanisms instead of treating symptoms
- (2021) Cristian Nogales et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis
- (2021) Dan-Dan Zhang et al. Cell Death & Disease
- Oridonin suppresses autophagy and survival in rheumatoid arthritis fibroblast-like synoviocytes
- (2020) Shou-Di He et al. PHARMACEUTICAL BIOLOGY
- Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ
- (2020) Zhishen Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- SnapShot: FABP Functions
- (2020) Bing Li et al. CELL
- Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
- (2020) Ron C Hoogeveen et al. CLINICAL CHEMISTRY
- Oridonin alleviates d‐ Gal N/LPS ‐induced acute liver injury by inhibiting NLRP3 inflammasome
- (2020) Tao Zhang et al. DRUG DEVELOPMENT RESEARCH
- An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions
- (2020) Desislava (Daisy) Ilchovska et al. AUTOIMMUNITY REVIEWS
- Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice
- (2020) Tongxin Song et al. BIOMEDICINE & PHARMACOTHERAPY
- Immunity and Inflammation in Atherosclerosis
- (2019) Dennis Wolf et al. CIRCULATION RESEARCH
- Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
- (2019) Magnus Bäck et al. Nature Reviews Cardiology
- Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
- (2019) Masato Furuhashi Journal of Atherosclerosis and Thrombosis
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
- (2019) Agha Zeeshan Mirza et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Atherosclerosis and Nanomedicine Potential: Current Advance and Future Opportunities
- (2019) Fan Jiang et al. CURRENT MEDICINAL CHEMISTRY
- Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways
- (2019) Huahong Yang et al. Cell Communication and Signaling
- Antioxidants and Atherosclerosis: Mechanistic Aspects
- (2019) Khojasteh Malekmohammad et al. Biomolecules
- Beneficial effects of Oridonin on myocardial ischemia/reperfusion injury: Insight gained by metabolomic approaches
- (2019) Junhong Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A FABP4-PPARγ signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes
- (2019) M. Lamas Bervejillo et al. Redox Biology
- Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling
- (2019) Nanding Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment
- (2019) Sanne J. C. M. Frambach et al. PHARMACOLOGICAL REVIEWS
- Regulation of macrophage immunometabolism in atherosclerosis
- (2018) Graeme J. Koelwyn et al. NATURE IMMUNOLOGY
- Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA
- (2018) Tamer Sallam et al. NATURE MEDICINE
- Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities
- (2017) Weiyan Cheng et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- NF-κB inhibitors that prevent foam cell formation and atherosclerotic plaque accumulation
- (2017) Jesse D. Plotkin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- FABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2
- (2016) Kaylee A. Steen et al. MOLECULAR AND CELLULAR BIOLOGY
- Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao
- (2016) Dahong Li et al. MOLECULES
- CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
- (2016) Yoko Kojima et al. NATURE
- Epidermal Fatty Acid Binding Protein Promotes Skin Inflammation Induced by High-Fat Diet
- (2015) Yuwen Zhang et al. IMMUNITY
- LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2
- (2015) Maryem A. Hussein et al. PLoS One
- The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells
- (2012) Hiu-Yee Kwan et al. JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started